BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+19.29%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.67B
AUM Growth
+$2.67B
(+4.9%)
Cap. Flow
+$75.1M
Cap. Flow
% of AUM
2.82%
Top 10 Holdings %
Top 10 Hldgs %
52.29%
Holding
77
New
9
Increased
18
Reduced
19
Closed
10
Top Buys
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$200M |
| 2 |
argenx
ARGX
|
$68.1M |
| 3 |
IMA
ImageneBio, Inc. Common Stock
IMA
|
$45.2M |
| 4 |
Cullinan Oncology
CGEM
|
$43.7M |
| 5 |
Merus
MRUS
|
$30.9M |
Top Sells
| 1 |
Cytokinetics
CYTK
|
$101M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$56.2M |
| 3 |
Xencor
XNCR
|
$55.2M |
| 4 |
ALX Oncology
ALXO
|
$46.6M |
| 5 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
$29.2M |
Sector Composition
| 1 | Healthcare | 98.46% |
| 2 | Financials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIRX
26
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $28.6M | 1.07% | 3,094,174 +1,366,866 | +79% | +$12.6M |
|
27
Verastem
VSTM
$569M
| $28.4M | 1.06% | 11,480,994 +300,000 | +3% | +$741K |
|
|
INFI
28
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $27.1M | 1.02% | 8,383,645 -9,043,323 | -52% | -$29.2M |
|
29
Ovid Therapeutics
OVID
$91M
| $25.8M | 0.97% | 6,417,551 +1,895,500 | +42% | +$7.62M |
|
30
AnaptysBio
ANAB
$569M
| $25.6M | 0.96% | +1,189,500 | New | +$25.6M |
|
31
Forte Biosciences
FBRX
$137M
| $24.6M | 0.92% | 718,788 | – | – |
|
|
CALT
32
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| $20.7M | 0.78% | 750,000 | – | – |
|
|
CTIC
33
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $20.2M | 0.76% | 6,929,690 | – | – |
|
34
Sutro Biopharma
STRO
$72.7M
| $18.8M | 0.71% | 826,825 -1,027,337 | -55% | -$23.4M |
|
35
Immunovant
IMVT
$2.56B
| $18.4M | 0.69% | 1,144,016 +629,646 | +122% | +$10.1M |
|
|
CFRX
36
DELISTED
ContraFect Corporation
CFRX
| $18.3M | 0.69% | 3,812,300 +2,212,300 | +138% | +$10.6M |
|
|
GRTS
37
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $17.6M | 0.66% | 1,861,239 -834,179 | -31% | -$7.87M |
|
|
SLN
38
Silence Therapeutics
SLN
$227M
| $15.8M | 0.59% | +666,666 | New | +$15.8M |
|
39
Elicio Therapeutics
ELTX
$172M
| $15.8M | 0.59% | +875,000 | New | +$15.8M |
|
|
PVLA
40
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $14.1M | 0.53% | 5,494,582 | – | – |
|
41
Replimune Group
REPL
$422M
| $14.1M | 0.53% | +461,428 | New | +$14.1M |
|
|
CALA
42
DELISTED
Calithera Biosciences, Inc
CALA
| $13.5M | 0.51% | 5,566,690 +1,205,452 | +28% | +$2.92M |
|
43
Cogent Biosciences
COGT
$1.69B
| $13.5M | 0.5% | 1,532,282 | – | – |
|
44
MEI Pharma
MEIP
$160M
| $12.3M | 0.46% | 3,588,155 -461,007 | -11% | -$1.58M |
|
45
Eledon Pharmaceuticals
ELDN
$155M
| $11.9M | 0.45% | 1,113,435 +350,156 | +46% | +$3.75M |
|
|
GNCA
46
DELISTED
Genocea Biosciences, Inc.
GNCA
| $10.9M | 0.41% | 4,012,404 | – | – |
|
47
Cartesian Therapeutics
RNAC
$261M
| $10.8M | 0.4% | 2,379,986 -924,977 | -28% | -$4.19M |
|
|
AMRN
48
Amarin Corp
AMRN
$311M
| $10.7M | 0.4% | 1,715,981 -9,045,612 | -84% | -$56.2M |
|
49
Cidara Therapeutics
CDTX
$1.66B
| $9.95M | 0.37% | 3,739,704 | – | – |
|
50
Corvus Pharmaceuticals
CRVS
$428M
| $9.95M | 0.37% | 3,229,426 +1,285,714 | +66% | +$3.96M |
|